Literature DB >> 30530727

Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.

Fábio F Rosa1,2,3, Cristiana F Pires1,2,3, Ilia Kurochkin4, Alexandra G Ferreira1,2,3, Andreia M Gomes3, Luís G Palma3, Kritika Shaiv3, Laura Solanas3, Cláudia Azenha3, Dmitri Papatsenko4, Oliver Schulz5, Caetano Reis e Sousa5, Carlos-Filipe Pereira6,2,3.   

Abstract

Ectopic expression of transcription factors has been used to reprogram differentiated somatic cells toward pluripotency or to directly reprogram them to other somatic cell lineages. This concept has been explored in the context of regenerative medicine. Here, we set out to generate dendritic cells (DCs) capable of presenting antigens from mouse and human fibroblasts. By screening combinations of 18 transcription factors that are expressed in DCs, we have identified PU.1, IRF8, and BATF3 transcription factors as being sufficient to reprogram both mouse and human fibroblasts to induced DCs (iDCs). iDCs acquire a conventional DC type 1-like transcriptional program, with features of interferon-induced maturation. iDCs secrete inflammatory cytokines and have the ability to engulf, process, and present antigens to T cells. Furthermore, we demonstrate that murine iDCs generated here were able to cross-present antigens to CD8+ T cells. Our reprogramming system should facilitate better understanding of DC specification programs and serve as a platform for the development of patient-specific DCs for immunotherapy.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2018        PMID: 30530727     DOI: 10.1126/sciimmunol.aau4292

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  18 in total

1.  Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.

Authors:  Fábio F Rosa; Cristiana F Pires; Ilia Kurochkin; Evelyn Halitzki; Tasnim Zahan; Nejc Arh; Olga Zimmermannová; Alexandra G Ferreira; Hongzhe Li; Stefan Karlsson; Stefan Scheding; Carlos-Filipe Pereira
Journal:  Sci Immunol       Date:  2022-03-04

Review 2.  Genetic models of human and mouse dendritic cell development and function.

Authors:  David A Anderson; Charles-Antoine Dutertre; Florent Ginhoux; Kenneth M Murphy
Journal:  Nat Rev Immunol       Date:  2020-09-09       Impact factor: 53.106

3.  Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.

Authors:  Fábio F Rosa; Cristiana F Pires; Olga Zimmermannova; Carlos-Filipe Pereira
Journal:  Bio Protoc       Date:  2020-05-20

Review 4.  Cellular reprogramming: Mathematics meets medicine.

Authors:  Gabrielle A Dotson; Charles W Ryan; Can Chen; Lindsey Muir; Indika Rajapakse
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-12-02

Review 5.  Understanding and Modulating Immunity With Cell Reprogramming.

Authors:  Cristiana F Pires; Fábio F Rosa; Ilia Kurochkin; Carlos-Filipe Pereira
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

Review 6.  The Intriguing History of Cancer Immunotherapy.

Authors:  Paula Dobosz; Tomasz Dzieciątkowski
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

7.  Directly reprogrammed natural killer cells for cancer immunotherapy.

Authors:  Han-Seop Kim; Jae Yun Kim; Binna Seol; Cho Lok Song; Ji Eun Jeong; Yee Sook Cho
Journal:  Nat Biomed Eng       Date:  2021-08-02       Impact factor: 25.671

Review 8.  Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications.

Authors:  Annalisa Del Prete; Francesca Sozio; Ilaria Barbazza; Valentina Salvi; Laura Tiberio; Mattia Laffranchi; Angela Gismondi; Daniela Bosisio; Tiziana Schioppa; Silvano Sozzani
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 9.  Mapping regulators of cell fate determination: Approaches and challenges.

Authors:  Aditya Kumar; Prashant Mali
Journal:  APL Bioeng       Date:  2020-07-01

Review 10.  Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.

Authors:  Kenichi Horisawa; Atsushi Suzuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.